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Abstract
Scientists are now able to directly convert one somatic cell type into another using a pro-
cedure known as direct lineage reprogramming or transdifferentiation. In this procedure,
transcription factors which are important for initiating a rewriting of the gene expres-
sions are introduced in the cell. One specific type of reprogramming involves generating
dopamine producing neurons from human adult fibroblast skin cells. The transdifferentia-
tion procedure in human cells has proven challenging. So far, conversion schemes are not
able to generate satisfactory levels of mature neurons. However, experimental efforts are
made to overcome this. Succeeding in generating a high yield conversion scheme would
open up new pathways for medical treatments and disease modeling of diseases such as
Parkinson’s disease.
In this thesis, we study a model built in silico for a gene circuit proven to be important in
the transdifferentiation from human adult fibroblast cells to neurons. Using experimental
time series of gene expression obtained from a recently found high-yield neural conversion
scheme, the model is capable to capture the experimental data dynamics. The system
exhibits at least two attractors: one representing a neuronal state, and the other a non-
neuronal state. A stochastic simulation was conducted for identifying strategies leading to
high-yield neural conversion. The aim of the model presented here is to improve our un-
derstanding of the underlying dynamics, which may lead to a high yield neural conversion
scheme applicable in vitro and in vivo.
Popula¨rvetenskaplig sammanfattning
Gener fungerar som instruktioner fo¨r vad cellen skall producera. Det a¨r aktiveringen och
ha¨mningen av gener som ger upphov till ma˚nga olika typer av celler i ma¨nniskans kropp
som till exempel hudceller, blodceller och nervceller. Dessa celler samarbetar med varandra
fo¨r att tillsammans skapa den flercelliga organismen: ma¨nniskan. Det finns tv˚a huvudkate-
gorier av celler i kroppen, somatiska celler samt ko¨nsceller. Nervceller och hudceller tillho¨r
allts˚a gruppen somatiska celler.
Skadade somatiska celler kan leda till sjukdomar som till exempel Parkinsons sjuk-
dom. Denna sjukdom fo¨rknippas med en nedsatt produktion av signalsubstansen dopamin.
Dopamin produceras av nervceller i hja¨rnan och a¨r viktig fo¨r till exempel motoriken i krop-
pen. Ett alternativ a¨r att byta ut de skadade nervcellerna mot friska celler, men detta
medfo¨r etiska dilemman d˚a va¨vnaden som transplanteras tas fr˚an aborterade foster.
Under senare a˚r har forskning lett till att en ny typ av teknik utvecklats som involverar
omprogrammering av patientens egna celler. Genom att injicera olika a¨mnen i cellen a¨r
det mo¨jligt att a¨ndra vilka gener som aktiveras och ha¨mmas. P˚a s˚a vis a¨r det mo¨jligt
att a¨ndra celltypen fo¨r somatiska celler. Till en bo¨rjan skedde omprogrammeringen via
ett stamcellsstadium, men denna teknik har visat sig ha en fo¨rho¨jd risk av tumo¨rbildning.
Ista¨llet anva¨nds direktomvandling, en omprogrammeringsstrategi da¨r en somatisk celltyp
direkt o¨verg˚ar till en annan utan det mellanliggande stadiet. Med denna metod a¨r det
mo¨jligt att till exempel generera nervceller direkt fr˚an hudceller. A¨n s˚a la¨nge a¨r andelen
celler som omvandlas relativt l˚ag hos vuxna individer. Detta a¨r en sv˚arighet som beho¨ver
lo¨sas fo¨r att metoden skall bli anva¨ndbar i praktiken.
Vi har gjort en na¨rmare studie av genregleringen i direktomvandling fr˚an hudceller till
nervceller hos vuxna ma¨nniskor. Samspelet mellan generna skapar ett avancerat na¨tverk
som beskriver omvandlingen p˚a en molekyla¨r niv˚a. Genom att kombinera etablerade in-
teraktioner med ett antal hypotetiska interaktioner har vi lyckats hitta ett na¨tverk som
beskriver experimentell data i datorsimuleringar. Studier av detta na¨tverk kan ge en in-
blick i de underliggande processerna som styr direktomvandling mellan hud- och nervceller.
En vidareutveckling av modellen s˚a att dopaminproducerande nervceller inkluderas skulle
kunna leda till en uto¨kad fo¨rst˚aelse av direktomvandling fr˚an hud- till nervcell. Detta kan
i sluta¨ndan ge effektivare omvandlingsstrategier vilket har stor potential fo¨r medicinska
metoder i kampen mot till exempel Parkinsons sjukdom.
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List of Abbreviations
Notation Description
Ascl1 A neuronal gene, often used in transdifferen-
tiation between HAF and neuron.
Brn2 A neuronal gene, involved in the maturation
of reprogrammed neurons.
HAF Human Adult Fibroblast, a cell type that
build connective tissue between organs in the
body.
iPS Induced Pluripotent Stem cell.
miR microRNA, small non-coding RNA molecules
that regulate gene expression.
miR-124 A neuronal miR, associated with silencing
non-neuronal gene expression.
miR-9 A neuronal miR, associated with silencing
non-neuronal gene expression.
mRNA messenger RNA, transcribed from the gene se-
quence on the DNA.
nPTB Neural PTB, a neuronal gene that is upregu-
lated in neuronal cells.
PTB A non-neuronal gene, upregulated in non-
neuronal cells.
REST A non-neuronal gene that together with other
components build the REST complex.
RESTc REST complex, a protein complex that re-
presses many neuronal genes. It is built from
REST protein and components it recruits.
RESTi REST inhibition, a factor that represses the
gene expression of REST.
SCP1 A non-neuronal gene, a component of RESTc.
shREST Short Hairpin REST, equivalent to RESTi.
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1 Background
The body is constructed by a vast amount of different cell types that range from skin
cells to nerve cells. It is the gene expression that define these cells. As a result, skin cells
and nerve cells have different functions while possessing the same DNA. Collectively, the
cells that build a multicellular organism constitute two major categories: somatic cells and
reproductive cells. The group of somatic cell types is the largest.
In humans, pathological somatic cells lead to diseases such as Parkinson’s disease, which
is characterized by ceased production of dopamine by neurons in the brain1. A relatively
new type of treatment known as regenerative treatment is used to rejuvenate cells, tissues
and organs of the human body. By replacing unhealthy cells the treatment aim to establish
normal function of the organs.
For nerve damage and other types of cell related illnesses, cell therapy, a branch of
regenerative treatment, is used. In this medical treatment, cells are transplanted to the
patient with the intention of restoring damaged nerves. From the end of the twentieth
century there have been clinical trials using cell therapy performed on Parkinson’s disease
patients2. Results were promising with some patients having long-lasting and pronounced
effects after a transplantation, allowing for medication withdrawal. However, the treat-
ment is not free from ethical controversies as the tissue being transplanted is taken from
fetuses2,3.
A new branch of medical research, free of ethical disputes, involves transplanting the
patient’s own cells. In this medical treatment, somatic cells are reprogrammed to stem
cell-like states using a cocktail of gene promoting or silencing factors. The factors are
transducted, inserted using a viral vector or virus, inside the somatic cells in vitro. As
the cells begin to produce messenger RNAs (mRNAs) for stem cells and repress mRNAs
specific for the current somatic cell type, a conversion occurs. The cells are converted to a
stem cell-like state ready for differentiation to the desired somatic type. The differentiated
cells are then transplanted into the patient.
Recently, somatic cells have been reprogrammed to embryonic-like states using tran-
scription factors to revert the differentiation of the cell. In 2006, Takahashi and Yamanaka4
managed to reprogram mouse somatic cells to a pluripotent state denoted induced pluripo-
tent stem (iPS) cells. Later on, in 2007, Takahashi et al. 5 and Yu et al. 6 also managed
to reprogram human adult fibroblast (HAF) to iPS cells using a set of four transcription
factors. These mouse and human iPS cells exhibited similar characteristics such as mor-
phology and proliferation found in their embryonic stem cell counterparts. As mentioned
in the report by Takahashi et al. their results suggest that a fundamental transcriptional
network governs the pluripotency in human and mouse cells, but external factors main-
taining the pluripotency are different for the species.
An issue with iPS cells that needs to be addressed before starting clinical trials on hu-
mans, is the development of tumors7. This has led to research on a new technique known
as direct lineage conversion8. Direct lineage conversion, also known as transdifferentiation,
is a technique that forces a somatic cell directly to another somatic cell type without the
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intermediate pluripotent state. The advantage of using this method is that the unstable
pluripotent state is avoided, reducing the tumorigenicity of the cells. In a similar fashion to
iPS cell generation, a cocktail of gene regulating factors are transducted into the cell.
Research on the transdifferentiation from fibroblast to neuron suggest there exists key
regulatory genes important for the reprogramming. Here a brief introduction to the genes
considered in this study is given. Previously, a cocktail using transcription factors Ascl1,
Brn2, and Myt1l, has been used to achieve direct lineage conversion from mouse embryonic
fibroblast cells to induced neuron cells9. Ascl1 was shown to be the driving mechanism
of the neuronal reprogramming10. This work inspired research on human cells, converting
fibroblast cells to induced neuron cells11–15. Interestingly, using the previous cocktail for
mouse embryonic fibroblast cells resulted in immature induced neuron cells in humans13,14.
Despite this, all studies reported an optimal cocktail for reprogramming using one or more
of the three transcription factors used on mouse, in combination with other factors.
Continuing the discussion on regulatory genes, Yoo et al. 12 reported that human fi-
broblasts could be reprogrammed using microRNA (miR) 124 and 9 combined with Ascl1
and other transcription factors. These miRs are small molecules that help regulate gene
expression. Two important genes regulated by miR-124 and miR-9 is SCP116 and REST17,
respectively. The REST factor represses a large set of neuronal genes by binding to their
respective DNA site and preventing their gene expression18,19. At the binding site it forms
a complex (RESTc) by recruiting co-factors19. Among the co-factors recruited is SCP1.
This factor has shown to be influential in neuronal gene repression of non-neuronal cells20.
Another important component that is repressed by miR-124, is the PTB protein21. The
PTB protein is upregulated in non-neuronal cells and downregulated in neuronal cells. An
anti-correlated gene associated with PTB down- and upregulation is neural PTB (nPTB).
One reason for this behavior is that PTB represses nPTB21,22.
The mentioned genes have recently been combined into two regulatory loops. In a 2013
paper, the first regulatory loop was found that induced transdifferentiation from mouse
embryonic fibroblast cells to neurons by knockdown of PTB23. Later, a study on HAF
cells showed that in humans, a second regulatory loop is important for the maturation
process24. The two regulatory loops consist of Brn2, miR-124, miR-9, RESTc, PTB, and
nPTB; genes that, as previously mentioned, are important for fibroblast to neuron trans-
differentiation in human.
Being able to generate induced neuron cells from HAF cells, using direct lineage repro-
gramming pose an exciting new method for disease modeling and medical applications of
neurodegenerative diseases. An issue using this method is the relatively low efficiency of
reprogramming14. However, recently our collaborators Malin Parmar and Janelle Drouin-
Ouellet at Lund university managed to improve the methods efficiency to relatively high
yields25. They found that REST acts as a reprogramming barrier that prevents neuronal
genes expression, in line with previous studies23,24.
To gain further knowledge of the underlying mechanisms and to potentially improve
the conversion scheme, we have studied here the neural conversion in silico. An advan-
tage of in silico approaches, compared to in vitro or in vivo approaches, is the short time
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scale required. Here, testing dynamics of the transdifferentiation is relatively effortless and
performed in a couple of days. Merging the regulatory loops mentioned above and incor-
porating the cocktail found by our collaborators, we have tested different regulatory gene
network topologies. Associated with each topology is a set of rate equations with unknown
parameters that describe how each gene expression evolves in time in a deterministic way.
Provided with experimental time series data for Ascl1, Brn2, miR-124, miR-9, REST,
SCP1, PTB, and nPTB, from our experimental collaborators, we found an optimal set of
parameter values for each topology using two global search methods, simulated annealing
and genetic algorithm. The best performing regulatory gene network is able to capture
the main features of experimental time series data. The winning topology is also used to
simulate an ensemble of 100 cells stochastically. We found that perturbing a component
of RESTc resulted in cells either converting to a neuronal-like state or a non-neuronal
like state. Thus, the model presented in this thesis might prove useful in furthering our
knowledge of the underlying processes that guide HAF to neuron transdifferentiation in
humans.
1.1 Model
RESTc
miR-124
PTB
Figure 1: The first regula-
tory gene loop, important
for the transdifferentiation
process to a human neuron
cell.
In this section the network and its components will be dis-
cussed in more detail, providing an overview of the interac-
tions between them. The goal is to introduce the nodes in
the network, their interactions, and how we can build a net-
work out of these. The section is concluded with a figure
illustrating a basic regulatory gene network built from the
interactions presented.
1.1.1 Two regulatory loops
In 2013, Xue et al. 23 were able to show that several cell
types, for example human embryonic stem cells, differenti-
ated into neuron-like states when a protein known as PTB
was repressed. The conversion was governed by a network
consisting of PTB, microRNA miR-124, and REST complex
(RESTc), see figure 1.
Here is a brief description of the genes in the network.
PTB is a non-neuronal protein that functions as a negative
regulator of neuronal genes in non-neuronal cells22. RESTc
consists of the REST protein and the components recruited
by this factor19. It acts as a reprogramming barrier, repressing several neuronal genes
in non-neuronal cells19,23,25. This complex is built from REST and the components re-
cruited by this protein at the gene site18. One such component is SCP1, a REST co-factor.
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Yeo et al. 20 showed that SCP1 is being recruited by REST to serve an important role in
the repression of neuronal genes in non-neuronal cells. By repressing SCP1 together with
REST activity Yeo et al. were able to further enhance the neuronal conversion rate. miR-
124 is a microRNA, derived from non-coding sequences (not translated into protein) of
mRNA26–28. MicroRNA, once transcribed, regulates gene expression by binding to mRNA
post-transcriptionally, preventing translation of the targeted gene. Thus, microRNAs are
important regulators of gene expression.
Here follows a short description of the interactions we included in this study. The three
mentioned nodes form a regulatory loop in which an increased regulation of PTB and
RESTc translates to high repression of neuronal genes. Converting to a neuron state is
accomplished by repressing both PTB and RESTc. As shown in Xue et al., both miR-124
and PTB have targeting sites on SCP1. Knockdown of PTB enhanced suppression of SCP1
and overexpression of miR-124 had a similar effect. We model RESTc as composed of two
parts, REST and SCP1. This choice is based on studies20,23, and that for our purposes the
other RESTc co-factors appear less influential. In our model, PTB activates SCP123, miR-
124 represses SCP116 and PTB21, while REST complex represses miR-12423, see figure
1.
Brn2
miR-9
nPTB
Figure 2: The second regu-
latory gene loop, important
for the maturation process
of a human neuron cell.
In 2016, Xue et al. 24 reported that deactivating neuronal
repression through the above mentioned regulatory loop on
HAF cells produced immature neurons. They announced to
have found a secondary loop, important for neuron matura-
tion in human. This loop contains neural PTB (nPTB), the
transcription factor Brn2, and the microRNA miR-9, see fig-
ure 2. Note that Ascl1 denote a combined node of Ascl1 and
Brn2 which will be explained shortly. This regulatory loop
is activated by repressing nPTB once transdifferentiation to
neuron-state has occurred. The sequential process is impor-
tant for producing functional neurons in humans24.
Here a short description of the reported genes is given.
nPTB is similar in structure to its non-neuronal paralog
PTB22. PTB is expressed in non-neuronal cells and nPTB
is expressed in neuronal cells. Brn2 is a transcription factor
used for neuronal conversion and important for the matura-
tion of converted cells9,13,24,25. It is upregulated in matur-
ing neurons and repressed in non-neuronal cells. MicroRNA
miR-9 has, in similar fashion to miR-124, an important role
in gene regulation29. Xue et al. found that both miR-124 and
miR-9 serve a role of repressing nPTB in maturing neurons,
however miR-124 targets nPTB relatively weakly in compar-
ison to PTB21,24.
Incorporating our collaborators reprogramming cocktail required the transcription fac-
tor Ascl1 to be introduced. Ascl1, similar to Brn2, is upregulated in the neuronal state30.
10
In mouse cells neuronal reprogramming is driven by Ascl1, which recruits Brn2 to many
of its binding sites10,31. It has been shown that overexpression of Ascl1 alone could in-
duce human fibroblasts to cells with neuron-like phenotype11. In combination with the
non-neuronal gene repressors miR-124 and miR-9, Ascl1 helps human neuronal reprogram-
ming12. For these reasons, Ascl1 and Brn2 can be considered as a single node that drives
neuronal transdifferentiation. In our models we combine Ascl1 and Brn2 into a single node
that is denoted Ascl1.
The three mentioned nodes form the second regulatory loop, which is important for
the maturation of immature neurons in humans. This subsequent paragraph explains the
interactions incorporated in our model. In the second loop overexpression of Brn2 triggers
the expression of neuronal genes by upregulating microRNAs 124 and 9.24 In our model
this is represented by overexpression of Ascl1. Xue et al. 24 reported that nPTB represses
Brn2 since knockdown of PTB had small effects on Brn2 levels, while sequential knockdown
of PTB and nPTB induced Brn2. Xue et al. also reported that Brn2 targets both miR-124
and miR-9. These interactions were included in our network as well. As mentioned above,
microRNA miR-9 represses nPTB24, also included in this study.
In summary, transdifferentiation from a fibroblast state to a neuron state is controlled
by a regulatory loop consisting of PTB, miR-124, and RESTc. Activating conversion
from a non-neuronal state to a neuronal state is achieved by repressing PTB and RESTc.
Together, these genes create the first regulatory loop, summarized below.
• First regulatory loop
– miR-124 represses PTB, and RESTc through SCP1
– PTB activates RESTc through SCP1
– RESTc represses miR-124
From the immature neuronal state the cell is matured using a second regulatory loop.
This loop consists of nPTB, miR-9, and Ascl1 and Brn2. Together, these genes create the
second regulatory loop, summarized below.
• Second regulatory loop
– nPTB represses Brn2
– miR-9 represses nPTB
– Ascl1 activates miR-9
These genes constitute the basic nodes in our regulatory gene network.
1.1.2 Merging the two regulatory loops
The two regulatory loops in section 1.1.1 build the regulatory gene network. To gain fur-
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ther insight on the transdifferentiation scheme we model these two loops in silico. The
loops are intertwined, and not independent of each other24. Therefore the gene expression
of one node is affecting the gene expression of the other nodes. As a consequence they
have to be merged.
Here the interactions that connect the two regulatory gene loops are described. In
similar fashion to a previous study, the regulatory gene network is built from experimen-
tally determined interactions32. Studies have shown that PTB is repressing nPTB33,34. In
non-neuronal cells PTB is expressed in higher concentrations, and in neuronal cells nPTB
is expressed in higher concentrations. Downregulation of PTB has a positive effect on
nPTB expression which makes a connection between the two regulatory loops. As men-
tioned in the previous section, Brn2 activates both miR-124 and miR-9. This combined
with the fact that Ascl1 could induce transdifferentiation in combination with miR-124
and miR-9 suggest that the Ascl1 node in our model activates both microRNAs. In addi-
tion, RESTc has targeting sites on Brn2 and Ascl1, as well as on miR-124 and miR-9.23
Repression of RESTc in PTB downregulated cells resulted in induced expression of these
four components. Since RESTc is associated with neuronal gene repression, and Ascl1,
Brn2, miR-124, and miR-9, is associated with neuronal gene promotion, RESTc is likely
a repressor of these 4 nodes. These interactions, together with those described in section
1.1.1, connect the two regulatory loops, forming the basic structure of the regulatory gene
network. An example of a network topology is shown in figure 3. This network is based
on previously discussed connections.
nPTBPTB
miR-124
Ascl1
SCP1 REST
RESTc
miR-9
Figure 3: Basic topology of the regulatory gene network. The connections made between
nodes constitute experimentally determined interactions. Note that Ascl1 and Brn2 are
characterized by a single node denoted Ascl1. The different colour signals is explained in
figure 7 on page 28.
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2 Method
A theoretical study of a regulatory system and its evolution in time require mathematical
definitions and principles to properly be understood. In this section, the aim is to define
the methodologies used as well as providing a brief description of them.
2.1 Mathematical formalism
2.1.1 Gene interactions
The regulation of gene expression can be described mathematically in several different
ways. Two common principles for describing gene expression in a regulatory gene network
is the Hill-, respectively Shea and Ackers formalism. The Hill formalism constitutes an
approach centered around the Hill equation35. This equation is a generalization of the
Michaelis-Menten equation36, a model of enzyme kinetics when a single substrate can bind
to the enzyme. The Hill equation generalizes this to include n number of substrates,
considering cooperativity in binding to the enzyme. The second formalism is known as the
Shea and Ackers formalism, based on a statistical physics approach37. In this work, we
use the Shea and Ackers formalism.
A gene denotes a sequence of nucleotides, the building blocks of DNA. In total, there
exist four building blocks, A, T, C, and G. Forming hydrogen bonds with each other, these
nucleotides create long double-stranded sequences, the DNA38. The DNA holds the genetic
information that is used to build an organism. Gene expression is the rendering of this
genetic information to important machines: proteins. This process can be divided into two
main categories: transcription and translation39.
Formulating transcription
Transcription of a gene is performed by the enzyme RNA polymerase40,41. The initiation
of transcription starts with RNA polymerase binding to the site of the gene. In order
to bind with this site, factors known as transcription factors are required. In eukaryotes,
there are two main categories of transcription factors, general and specific40. The general
transcription factors are required for the transcription of any gene, as they recruit and
help RNA polymerase bind to the DNA. The specific transcription factors bind to specific
nucleotide sequences, either facilitating the assembly of general transcription factors and
RNA polymerase, or blocking this assembly. Thus, specific transcription factors either
promote or repress the transcription of a gene. Once RNA polymerase is bound to the
DNA, it may start walking along it, synthesizing mRNA.
The site where the RNA polymerase binds to the DNA is denoted the promoter. The
promoter can be in various states s depending on the presence of RNA polymerase (RNAp)
and transcription factors (TF), see figure 4. For a state sm, let ` denote the number of
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transcription factors able to bind to the promoter, ism,` whether the transcription factor is
bound or not, and jsm whether the RNAp is bound or not. The combination of all states
form a partition function, Z(s), of the promoter site, as shown below.
Z =
∑
s1...sm...sn
∏
`
[TF`]
ism,` [RNAp]jsme
−∆G(sm)
kBT . (1)
Here, the sum is over all possible states s and the product over all transcription factors
able to bind on the promoter site. Each state sm has a set of TFs and RNAp that are
either bound or unbound. Note that the square brackets represent the concentration of the
respective term. A TF that is bound to the promoter site have ism,` equal to an integer
larger than 0, and a RNAp that is bound to the promoter site have jsm equal to an integer
larger than 0. An unbound TF or RNAp have ism,` or jsm equal to 0. In the Shea and
Ackers formalism, ism,` and jsm represents the number of proteins bound of each species
to the promoter site. The exponential term depends on the Gibbs free energy, ∆G(sm),
of the state. This factor symbolizes the difference in free energy between the unbound
state and the bound state sm. Note that ∆G(sm) = 0 when sm is the state with no TFs
or RNAp bound. The exponential term also depends on the Boltzmann constant kB, and
the absolute temperature T . This exponential term is often denoted the binding affinity
parameter, K = e
∆G(sm)
kBT . For reasons that will be discussed in section 2.1.1, we absorb the
RNAp concentration in the binding affinity parameter, which is treated as an unknown
parameter in our model.
Promoter
Promoter
Promoter
Promoter
TF
RNApTF TF
1) 2)
3) 4)
Figure 4: A schematic illustration of
transcription. The gene is transcribed in
state 3. Green TF characterize an activa-
tor, and red TF characterize a repressor.
The arrow indicate the direction RNAp
walks during transcription.
The total partition function can be split into
two parts, symbolizing non-transcribing and
transcribing states,
Z =
∑
s
Z(s) = Z(off) + Z(on), (2)
where Z(off) is the sum of all non-transcribing
states and Z(on) the sum of all transcribing
states. The probability of transcribing with a
set of transcription factors able to bound to the
promoter is given by,
P (on) =
Z(on)
Z(off) + Z(on)
. (3)
Describing the transcription process math-
ematically is now plausible by combining two
terms. First is the transcription rate, or the
production of mRNA. This expression is proportional to equation (3). Second, synthesized
mRNA is not always translated to a protein. It may decay after a certain half life. This
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give rise to a second term, involving its degradation rate and the concentration of synthe-
sized mRNA. Combining these two terms give the final equation, describing the dynamics
of transcription as,
d[Λ]
dt
= αP (on)− γ[Λ]. (4)
Here, [Λ] is the mRNA concentration of gene Λ, α is the maximum rate of transcription, γ
is the degradation rate, and P (on) is the probability of transcribing mRNA. This equation
describes the dynamics of mRNA in our model. Translation of mRNA to protein is in
a similar fashion defined using a partition function. The reason we exclude it here is
explained in the next section.
Simplifying the rate equations
In this section, we will use equation (4) to derive a simplified rate equation of a single
gene, outlining the process of modeling. The aim is to present how the partition function
of Shea and Ackers was simplified. The section is concluded with a short example.
To model the gene expression of a single gene we first have to decide the scale of the
model. Should it describe the process of transcription or translation, or combine the two?
In this work, we model just the transcription process for two reasons. First, the protein
concentrations are unknown. Consequently, describing translation would result in two un-
known terms for each gene, the production and decay of its protein. Second, we wish to
make the model as simple as possible. With these points in mind, the continued discussion
will only consider transcription.
Describing transcription of a single gene requires knowledge of the different TFs and
RNAp configurations on the promoter. Accounting for all states is impractical when con-
structing a simplified model. Hence, an alternative approach is to reduce the number of
states by absorbing unknown terms, wherever possible, in the parameters of the model. To
simplify it even further, we are not including cross terms of specific TFs in the partition
function. Thus, only one activating specific TF can bind to the promoter at a time. Below,
we give a brief outlining of how general TFs and RNAp are absorbed.
A state, defined by the partition function in equation (1), depends on TFs and RNAp.
TFs are categorized in two groups, general and specific. Denote a general TF GTF. As-
suming there is an abundance of GTFs and RNAp, in comparison to specific TFs, their
concentration is constant. This means that once a specific TF is bound the assembly of
GTFs and RNAp is fast. The transcription rate of a gene Λ, having factors GTF, RNAp
and two specific TFs A and R, is then given as,
dΛ
dt
=α
[GTF]i2 [RNAp]j1/K2 + [GTF]
i3 [RNAp]j2 [A]H1/K3
1 + [GTF]i1/K1 + [GTF]
i2 [RNAp]j1/K2 + [GTF]
i3 [RNAp]j2 [A]H1/K3 + [R]H2/K4
− γ[Λ].
(5)
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Here, Ki represents binding affinities, A is an activator, and R is a repressor of the gene.
Using the assumption for the GTF and RNAp concentrations, we can then modify the above
formula by setting [GTF]i2 [RNAp]j1/K2 = b
′, [GTF]i3 [RNAp]j2/K3 = s′1, and K
−1
4 = s
′
2
representing background production and binding affinities. The modified rate equation
looks like
d[Λ]
dt
= α
b′ + s′1[A]
H1
1 + [GTF]i1/K1 + b′ + s′1[A]H1 + s
′
2[R]
H2
− γ[Λ]. (6)
This equation can be further simplified, since [GTF]i1/K1 is now a constant. Breaking
out 1 + [GTF]i1/K1 plus omitting the square brackets and rewriting the modified binding
affinities, yield the further simplified rate equation as,
dΛ
dt
= α
b+ (s1 · A)H1
1 + b+ (s1 · A)H1 + (s2 ·R)H2 − γΛ. (7)
This is the type of simplified rate equations we use, involving only specific transcription
factors. In the case of pure repression (A= 0), the b-dependent terms can be absorbed
by α. The binding affinities are again scaled. Hence, for pure repression, the resulting
simplified rate equation looks like
dΛ
dt
= α′
1
1 + (s′′2 ·R)H2
− γΛ. (8)
The simplifications performed here are the notation we will use from this point forward.
As an example, consider the PTB gene previously described in section 1.1.1, seen in
figure 1. It has one node affecting it, microRNA miR-124, which acts as a repressor. The
transcription rate of PTB is in this case described by equation (4) with P (on) = 1
Z
. Using
the shorthand notation of equation (8) the final expression becomes,
dP
dt
= α
1
1 + (s ·miR-124)H − γP. (9)
Here, miR-124 is only found in the denominator since it represses PTB. Note that the
background term has been absorbed in α, as previously mentioned. Using this type of
formalism, we can calculate the time evolution for a set of rate equations that describe a
regulatory gene network, see sections 2.2 and 2.3.
2.1.2 Complex formation
The REST complex is, in this model, constructed from two parts, SCP1 and REST. A
method of modeling such a complex is found in Olariu et al. 42 First, denote the unbound
concentration of REST and SCP1 for [Rfree] respectively [Sfree], and the bound or complex
concentration for [R|S]. Second, assume the system is in equilibrium. The rate of bound
and unbound REST and SCP1 form the following reaction equation,
[Rfree] + [Sfree]
k+−⇀↽−
k−
[R|S]. (10)
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Here, k+ and k− represents the production rate respectively degradation rate of the com-
plex. In equilibrium, the left hand side and right hand side are equal. The dimerization
constant, Kd, is the ratio between free and bound factors,
Kd ≡ k−
k+
=
[Rfree] · [Sfree]
[R|S] . (11)
For simplicity, we assume the concentration of R and S is constant such that
[Rtotal]=[Rfree] + [R|S], (12)
[Stotal]=[Sfree] + [R|S]. (13)
Inserting equations (12) and (13) back into (11), and solving for the REST complex
yields,
[R|S] = Kd + [Rtotal] + [Stotal]
2
−
√(
Kd + [Rtotal] + [Stotal]
2
)2
− [Rtotal][Stotal]. (14)
Note that only the negative solution is valid. For the positive solution [R|S] grows with
Kd so that [R|S] ≥ [Rtotal]+[Stotal]2 + |[Rtotal]−[Stotal]|2 = max{Rtotal, Stotal}, but [R|S] can never
exceed min{Rtotal, Stotal}.
2.2 Parameter optimization
In this section we will present the methods used to find suitable parameters for a set of
rate equations. Specifically, we will describe the methods in relation to the best performing
regulatory gene network, see figure 7 and rate equations (26)-(31) on page 28. In total, this
model has 45 parameters, one from the REST inhibition RESTi, one from the dimerization
constant Kd of RESTc, 13 from the binding affinities si, 5 from the background productions
bi, 6 from the maximum transcription rates αi, 13 from the exponents Hi, and 6 from the
degradation rates γi. The time evolution of the genes for a specific parameter set can then
be obtained through the rate equations. Finding a set of parameters that result in curves
similar to experimental data constitute a challenging task. Solutions are points in the
space spanned by the parameters characterizing satisfactory time evolutions of the genes.
Two common strategies for finding such solutions are genetic algorithms and the simulated
annealing approach. These methods use clever techniques to relatively quickly sample the
high dimensional space spanned by the parameters. In this study, we use both a simulated
annealing43–46 and a genetic algorithm47 approach to find a suitable solution.
2.2.1 Genetic algorithms
Based on natural selection, genetic algorithms simulate the process of biological evolution
on a population. An initial set (“population”) of candidate solutions are generated. Each
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solution (“individual”) corresponds to a set of parameters for the system. Using a fit-
ness function, each individual is ranked depending on their respective performance. This
ranking is used to increase or decrease the chance for an individual to generate (“breed”)
a new individual (“child”) in a stochastic selection process. Those that perform better
are more likely to be selected. A child is produced by applying two operations on the
selected individuals (“parents”). These two operations are crossover and mutation opera-
tions. Crossover is the process of combining the two parents, creating new children that
share characteristics with the parents. Mutation symbolizes a small change of some inher-
ited characteristic, having low probability.
In its most basic form, an individual can be illustrated as a binary string of 0:s and
1:s.47 For example, let an individual constitute 10 parameters, each able to attain integer
values up to 32. In this case, using binary representation each parameter is characterized
by 5 bits (25 = 32). Hence, the individual is represented by a 50 (5 · 10) bit string. A
simple method for selecting parents to breed involve choosing the best individuals from a
subset of the population. This method is known as tournament selection. Once a set of
parents have been selected the two genetic operations are performed. An easy to implement
crossover method would be to choose a random recombination point where the strings are
to be split. This type of crossover is known as 1-point crossover. Taking one part of each
parent, two new strings of 50 bits are created. Note that it is important to match the
strings such that the offspring retains the string size of the parents. These constitute 10
parameters, however the children created are now each a combination of the parents. The
final genetic operation involves mutating each bit by flipping the value from either 0 or 1 to
the corresponding 1 or 0 with a low probability. In this way a new individual is produced in
the genetic algorithm. The genetic algorithm continues to generate new populations with
better fitted individuals until a set number of generations have been produced or until a
stopping criterion is fulfilled. For more information of the specific individual representa-
tion, fitness function, selection process, crossover and mutation operations we used, see
appendix A.
2.2.2 Simulated annealing
The main idea behind simulated annealing is to sample many candidate solutions (“states”),
accepting the majority of them at the beginning then gradually decreasing the acceptance
rate while favoring improving states, settling the system in a stable state. Using a pa-
rameter (“artificial temperature”), the algorithm control the acceptance rate, simulating a
process of first heating the system and gradually cooling it. This action allows the system
to explore several different states. Calculating the performance (“artificial energy”) for
each state, the algorithm can separate states from each other. Thus, gradually settling the
system in a state with low energy as the temperature is cooled. By allowing energetically
unfavorable moves the algorithm can avoid local minima. In this way, simulated annealing
is able to find global minima.
The general scheme used in a simulated annealing algorithm consist of four steps. In
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the first step a random state is chosen. In our context this translates to a set of parameter
values corresponding to the binding affinities (si), Hill coefficients (Hi), background pro-
ductions (bi), degradation rates (γi), and maximum production rates (αi). To calculate the
performance of the generated state, a function that can translate each state to an artificial
energy is required. This function is often denoted the objective- or cost function. The
cost function is problem specific, and for this reason also customizable. The notation for
the cost of a state is E(s), where s is the state and E the cost function. The different
states form, through the cost function, an energy landscape with hills and crevasses. The
temperature is an artificial parameter that controls the acceptance rate or movement in
this energy landscape.
The second step of the algorithm is to generate a new candidate, also known as neigh-
boring state s′. Commonly, this state is obtained by changing a subset of parameters using
the present state. The new state is associated with a new energy E(s′). To traverse the
energy landscape by sampling states, a function that can generate new states from the
present state is required. This function is often denoted the candidate- or neighborhood
function, the function that generates s′. The neighborhood function, like the cost function,
is problem specific. An efficient neighborhood function can increase the algorithm perfor-
mance significantly.
At the third step, the decision to either accept or reject the neighboring state is made.
Based on the Metropolis algorithm, Simulated Annealing will accept or reject the neigh-
boring state with probability e−∆/T , where ∆ = E(s′)−E(s), and T is the given artificial
temperature at step t. The calculated value is compared to an uniformly drawn random
number in the interval (0, 1). If e−∆/T is larger than this random number, the state is
accepted. Note that state s′ is always accepted if E(s′) < E(s), and for E(s′) > E(s) there
exists a probability to accept state s′.
In the fourth step, the temperature is lowered. This lowers the acceptance of new states
with higher energy than the current state since the decision is dependent on the tempera-
ture. Here, the system should be in thermodynamic equilibrium at all times. In practice,
lowering the temperature is accomplished in discrete steps, consequently each cooling step
is associated with a relaxation time. This is the time it takes for the system to reach a
steady state again. For this reason, the temperature has to be lowered carefully using a
cooling scheme. The cooling scheme is, like the cost function and the neighborhood func-
tion, problem specific. The goal is to have as rapid cooling as possible while avoiding local
optima.
Together these four steps form the central idea of simulated annealing. A summary of
them are given below.
1. Generate an initial state s, temperature T , and calculate the cost E(s) associated
with state s.
2. Generate a neighboring state s′ and calculate its cost E(s′).
3. Accept or reject the neighboring state depending on the cost difference ∆ = E(s′)−
E(s), and temperature T . The new state is accepted with probability e−∆/T . If the
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thermalization criterion or stop criterion is not fulfilled, go to step 2.
4. Lower the temperature T and repeat from step 2 above. If the stop criterion is
fulfilled then stop.
Notice that step 2 and 3 are repeated many times before step 4. This is to thermalize
the system at each temperature, allowing it to reach a steady state. This also allows the
system to sample a larger region of the parameter space, which lower the probability of
the algorithm getting trapped in a local optima. For more information of the specific cost
function, cooling schedule and neighborhood function we used see appendix A.
In light of the algorithm descriptions given above, performing a simulated annealing or
genetic algorithm parameter search on the regulatory gene network requires initial condi-
tions, as well as unknown parameters, to be defined. We initialize each gene with the level
of concentration in the corresponding data point of that gene at time t = 0. This method
proved to give the best results in silico, but does not include the 3 days knockdown period
of REST, explained in section 3.1. Another important point is that the first data point is
not fitted using this method. This means that some information is lost due to excluding
this data; on the other hand, this method facilitates the parameter search in the region of
interest. The reason for this is that all nodes have been set to a concentration appropriate
for studying the dynamics over the critical time period.
2.3 Stochastic approach
Reactions at the cellular level depend on several factors, such as the surrounding environ-
ment and the involved electrical charges of the species reacting. In addition, reactions have
a probability to occur which depends on the concentration of each species in the reaction.
The deterministic approach, while able to provide curves that fit data relatively well, does
not capture the stochastic nature of the underlying processes. For this reason, a stochastic
approach is desirable. The Gillespie algorithm provides the framework to simulate the
time evolution of a chemically reacting system48. In this section a short derivation and
description of the algorithm is given.
In order to simulate the time evolution, two questions have to be answered. Given that
the system is in a state (X1, . . . , Xn) at time t, where Xi represent concentration of species
i, at what time does the next reaction occur and what type of reaction is it? To answer
these two questions, Gillespie introduces the likelihood of a specific reaction µ to occur in
an infinitesimal time interval dt given the system is in a state (X1, . . . , Xn) at time t.
aµdt = Probability of reaction µ to occur
in the infinitesimal time interval
dt, given the system is in a state
(X1, . . . , Xn) at time t.
(15)
Note that aµ will be a combination of the number of available reactants, Xi, and the
average probability that any distinct molecular pair react with each other. µ represents
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an integer number between 1 and M , where M is the number of possible reactions. The
second important definition is the reaction probability density function, P (τ, µ), defined
as,
P (τ, µ)dτ = The probability of the next reaction
being of type µ and for it to occur
in the infinitesimal time interval (t+
τ, t+ τ + dτ).
(16)
Here, τ is a continuous variable of time, (τ ≥ 0). Notice that if τ and µ are known, the
answer to the two questions is known. Using definition (15), it is now possible to calculate
definition (16) as the product of aµdτ , the probability of a reaction to occur at time τ , and
the probability, P0(τ), of no reaction to occur in time interval (t, t+ τ).
P (τ, µ)dτ = P0(τ) · aµdτ. (17)
The expression of P0(τ) is deduced by realizing that for no reaction to occur in a time dτ
the probability is [1 −∑ν aνdτ ], where ν is an index from 1 to M . The probability that
no reaction occurs in a time interval (τ, τ + dτ) is,
P0(τ + dτ) = P0(τ)
[
1−
M∑
ν=1
aνdτ
]
. (18)
The expression of P0(τ) is derived by dividing both sides in (18) with dτ , and rearranging
the equation, such that,
P0(τ + dτ)− P0(τ)
dτ
= −P0(τ)
M∑
ν=1
aν . (19)
The above equation defines the derivative of P0(t
′) with respect to time, meaning,
dP0(τ)
dτ
= −P0(τ)
M∑
ν=1
aν . (20)
Solving (20) yield the expression,
P0(τ) = e
−∑Mν=1 aντ . (21)
Inserting expression (21) into equation (17) and integrating both sides yield the final ex-
pression of the probability P (τ, µ),
P (τ, µ) =
aµe
−∑Mν=1 aντ , if τ ≥ 0 and µ =
1, . . . ,M ,
0, otherwise.
(22)
Note that P (τ, µ) depends on all reactants at every time t. From here on, a0 =
∑M
ν=1 aν , will
be used. Determining the two quantities τ and µ answer the questions stated previously:
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at what time does the next reaction occur and what type of reaction is it. Generating τ
and µ such that they follow the probability distribution (22) ensures that reactions occur
statistically and in proportion to their concentration. The two variables are generated by
the two equations below,
τ=
1
a0
ln
(
1
r1
)
, (23)
µ−1∑
ν=1
aν <r2a0 ≤
µ∑
ν=1
aν . (24)
Here, r1,2 are uniformly drawn pseudorandom numbers in the interval (0, 1). In equa-
tion (24), µ is the first index of summing aν such that their sum exceeds the product
between the pseudorandom number r2 and a0. The derivation of these two equations can
be found in Gillespie 49 .
The two questions stated previously can now be answered. Using the two formulas (23)
and (24), we know at what time the next reaction will occur and what type of reaction
it will be. The steps to simulating the regulatory gene network stochastically can now be
summarized in a pseudocode as the following,
1. Initialize time t = t0, and the concentrations (X1, . . . , Xn).
2. Calculate the total probability density sum a0 of all reactions.
3. Derive τ and µ using equations (23) and (24).
4. Update the system, t = t+τ , and Xi = Xi+xµ, where Xi is the current concentration
of gene i and xµ is a concentration change for that gene.
5. Repeat from step 2 or exit.
For the regulatory gene network, the mRNA of a gene is involved in two types of reactions,
production or degradation. In the Gillespie algorithm, production yields a positive contri-
bution, xµ > 0, and degradation a negative contribution, xµ < 0. In total, the number of
possible reactions, M , are twice as many as the number of rate equations used.
2.4 Reduced stochastic noise
Working with the stochastic implementation, the standard concentration change of unity,
often chosen for the Gillespie algorithm, proved to yield too extreme fluctuations. The
reason for this is that in comparison to the concentration levels measured experimentally,
a change of unity is very large. Thus, each concentration increment or decrement in the
stochastic simulation has to be scaled such that the noise does not overpower the underlying
dynamics. In order to reduce the noise, we modify both the level of expressed mRNA and
time increment by a constant c. This preserves the scaling of the system to fit with the
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normalized data. Denote the current level of mRNA of a gene for Xi, then the modified
mRNA expression and time increment used is given by,
Xi = Xi + c · xµ,
τ =
c
a0
ln
(
1
r1
)
,
0 ≤ c ≤ 1. (25)
Here, xµ is the standard unity change and τ the time increment, both multiplied by the
same constant c. This is to ensure that on average the same amount of reactions occur
in the time period. Determining the constant c is done by trial and error. In this work
c = 0.01.
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3 Results
3.1 Experimental data
Experiments injecting genetic material in the cell have been conducted since the mid-to-
late 20th century50,51. In the case of cell conversion, these experiments may test different
sets of reprogramming factors trying to find possible improvements in the differentiation
scheme and quality of the differentiated cells52. In this section, the experimental data is
explained in more detail.
Our collaborators Malin Parmar and Janelle Drouin-Ouellet have performed an in vitro
study using different viral vectors on human adult fibroblast cells25. The experiments were
conducted using HAF cell culture in petri dishes that are injected with a reprogramming
cocktail. By mounting the vectors with different reprogramming factors, different neuronal
conversion schemes can be studied. The mRNA concentration of a variety of genes is then
monitored during a 21 day period. The group used a total of 12 different cocktails with
varying degree of success. Results show that using a cocktail consisting of Ascl1, Lmxa1,
Lmxb1, FoxA1, otx2, Nurr1, and RESTi, performed the best. Here, Lmxa1, Lmxb1,
FoxA1, otx2, and Nurr1 are factors that facilitate production of dopamine of the converted
neurons, these are not included in our model.
The data of the 12 different cocktails are shown in figure 5. Here, the first histogram
to the left illustrates approximately the number of cells in use for each cocktail. The his-
togram in the middle shows the percentage of cells that transdifferentiate to a neuron-like
state, in relation to the initial number of cells. Note that cocktail number 10 performed
the best with a roughly 70% conversion rate. The last histogram indicate the percentage
of the transdifferentiated neuron-like cells that produce TH, an enzyme that facilitates
production of dopamine53.
Cells classified as not converted constitute both HAF cells and other types of immature
neurons which did not transdifferentiate accordingly. The reprogramming results in many
different types of neuron topologies. In this study, we do not make a distinction between
different neurons. The only criterion is that the neurons display normal physiology. In
the experiment, cells were classified as neuronal and non-neuronal by marking a protein
characteristic for neurons with green fluorescence protein (GFP) and sorting cells express-
ing this protein. Experimental data shows cocktail number 10 as being the best candidate
to achieve high conversion. Therefore, we use data gathered from cells grown on medium
with this cocktail to model transdifferentiation.
In figure 6 the time series of the mRNA concentration for the genes used in our model
are shown. Here, the orange dots connected with orange lines represent the median value.
Every time t has at most three measurements associated with it on the vertical axis. The
pale yellow shaded area illustrates the spread of data, meaning the highest respectively
lowest measured concentration at every median value used. The time series shown was
constructed by calculating an average between the present number of neurons and the
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Figure 5: Effectiveness of 12 different viral vectors tested experimentally25. First histogram
(left) displays initial number of cells. Second histogram (middle) displays the neuron
conversion rate of each vector from the first histogram. Third histogram (right) displays
the percent of cells from the second histogram that produce TH protein, a protein used in
the production of dopamine. We model conversion after time series data obtained using
cocktail number 10 since it performed the best.
initial number of undifferentiated cells at each time step. Each data point symbolizes a
bulk concentration from an independent time series of the single petri dish. The time
span of the experiment was 21 days in total, plus an initial 3 days of REST knockdown,
see appendix B. The REST knockdown phase is a required step in order to suppress the
repression of neural genes.
During the transdifferentiation process the concentration of each reprogramming factor
in a cell is difficult to control. Studying the data dynamics leads us to believe that the
important switch decisions are made within the first 5 days. Here, the time series of PTB,
REST, and SCP1 display a switch behavior around day 1. First, an initial downregulation
occurs between hour 0 and hour 8, followed by an upregulation till roughly day 1 and a
downregulation from that point to a steady state by day 5. Viewing the data, it appears
that this switch is an important step for the cell to convert. In a similar fashion, a switch
occurs around day 1 for neuronal genes nPTB, miR-124, and miR-9. After 5 days the
system seems to settle into a steady state with Ascl1, nPTB, and miRs high, see appendix
B. In the 5 days time period a trend is clearly visible; neuronal genes, endogenous Ascl1,
nPTB, miR-124, and miR-9, are being upregulated while the non-neuronal genes, PTB,
SCP1, and REST, are being downregulated. However there exists some flexibility in the
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Figure 6: Time series data showing the gene expression level for the genes in the model. The
pale yellow shaded area illustrates the maximum respectively the minimum values measured
during the experiment. The orange dots connected with orange lines illustrate the median
value at each measurement. Measurements shown exist at times (0, 8, 24, 48, 72, 120) mea-
sured in hours, converted to days on the x-axis. Every time t has at most three measure-
ments associated with it on the vertical axis. Note that this data is normalized such that
a value of 1 signifies the normal concentration in a fibroblast cell. Data shown here is for
the first 5 days, preceded by 3 days of REST knockdown.
exact dynamics since the time series are composed of independent time series. For this
reason, the true shape of the transdifferentiation curves is unknown. From the middle
histograms in figure 5, we know that most cells transdifferentiate. Hence, we denote the
time series neuronal states. We fit the model to the median value, the orange data points,
at times (0, 8, 24, 48, 72, 120) in hours. Time evolutions produced by the model deviating
from these states (meaning low concentration of Ascl1, miR-124, miR-9, nPTB, and high
concentration of REST, SCP1, and PTB), we denote non-neuronal states. Distinguishing
between the two states will be discussed further in section 3.4.
In summary, the best performing cocktail consisted of REST inhibition and Ascl1 over-
expression. These factors are transducted in the cell via viral vectors. The conversion
rate to neuronal-like cells using this cocktail was roughly 70%. REST inhibition and viral
Ascl1 are denoted RESTi and virA in our model. The experimental time series data are
composed from many independent time series. Each data point symbolizes a bulk concen-
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tration of the cells in the petri dish. The critical transdifferentiation processes occur in the
first 5 days period.
3.2 The regulatory gene network
This section will aim to further explain how we model the best performing regulatory
gene network, seen in figure 7 with equations (26)-(31). Here, we provide the motive
for introducing hypothetical interactions, the classification of neuronal and non-neuronal
states, treating viral and endogenous Ascl1 separately, merging the microRNA nodes, and
what the model symbolizes. The section is concluded with a list of the main assumptions
of the model.
Merging the two regulatory loops from section 1.1.1 with the interactions described
in 1.1.2, resulted in a network which gave unsatisfactory fits to the time series. In order
to improve the performance of the regulatory gene network, we modified its topology.
Previously, our collaborators found RESTc to be a key barrier in the reprogramming25.
For this reason, we focus on modeling interactions to and from RESTc and its components
in silico. By trial and error, we tested different hypothetical interactions in order to find a
set that yields a relatively good fit to data, see appendix C. We tried various combinations
systematically, focusing on RESTc and its components. Fitting both SCP1 and REST to
data proved challenging as their central role in the network affects the fitting of all other
genes. RESTc interacting with its components improved the ability for the regulatory gene
network to fit data. Combining complex-to-component interactions with other interactions
we were able to find a winning network.
The best performing topology is determined by having the lowest cost or fitness, and
by not having an apparent unphysical behaviour. The winning topology we found is shown
in figure 7. The hypothetical interactions involve activation of PTB, SCP1, and REST
from RESTc, as well as activation of SCP1 and Ascl1 from nPTB. Note that all of these
interactions (except the Ascl1 activation) act to facilitate the plasticity of the involved
genes, PTB, SCP1, and REST. In the figure, rectangular nodes represent the experimental
cocktail used for transdifferentiation. REST inhibition is denoted short hairpin REST,
shREST, known as RESTi in the rate equations.
The set of rate equations of the winning topology is given by equations (26)-(31). Here,
P, A, nP, and virA, denote PTB, endogenous Ascl1, nPTB, and viral Ascl1. Viral Ascl1 as
well as RESTi are transducted into the cell via viral vectors, explained in section 3.1. The
two microRNAs 124 and 9 have been merged to a single node, denoted miR. The reason
for this merge is explained in the next paragraph. In the rate equations, γi represents
inverse half-life times, si represents binding affinities, bi represents background productions,
αi represents maximum transcription rates, RESTi represents REST inhibition, and Hi
represents how many factors bind to the promoter. From a modeling perspective this term
represents the degree of non-linearity. In total, the model has 45 parameters.
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nPTBPTB
miR
Ascl1
SCP1 REST
RESTc
Viral Ascl1
shREST
Figure 7: Topology of the best performing regulatory gene network. Here, green connect-
ing arrows symbolize activation and red connecting arrows symbolize repression. Note the
three thicker activations from RESTc and the activation from nPTB to SCP1 and Ascl1.
These are hypothetical interactions added to the network. REST inhibition is denoted
short hairpin REST, shREST. The red transparent nodes portrays non-neuronal genes
and cyan transparent nodes portrays neuronal genes. Nodes with blue contour have a
rate equation and those with purple contour have not. Oval nodes characterize endoge-
nous genes, expressed by the cell, and rectangular nodes are transducted factors, inserted
externally in the cell.
dP
dt
= α1
b1 + (s1 · RESTc)H1
1 + b1 + (s1 · RESTc)H1 + (s2 ·miR)H2 − γ1 · P (26)
dA
dt
= α2
b2 + (s3 · nP)H3
1 + b2 + (s3 · nP)H3 + (s4 · RESTc)H4 − γ2 · A (27)
dSCP1
dt
= α3
b3 + (s5 · P)H5 + (s6 · RESTc)H6 + (s7 · nP)H7
1 + b3 + (s5 · P)H5 + (s6 · RESTc)H6 + (s7 · nP)H7 + (s8 ·miR)H8 (28)
− γ3 · SCP1
dREST
dt
= α4
b4 + (s9 · RESTc)H9
1 + b4 + (s9 · RESTc)H9 + RESTi − γ4 · REST (29)
dnP
dt
= α5
1
1 + (s10 ·miR)H10 + (s11 · P)H11 − γ5 · nP (30)
dmiR
dt
= α6
b5 + (s12 · virA)H12
1 + b5 + (s12 · virA)H12 + (s13 · RESTc)H13 − γ6 ·miR (31)
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The two microRNAs, miR-124 and miR-9, described in earlier sections, have interac-
tions of similar nature. Both microRNAs regulate similar genes. For example, miR-124 and
miR-9 have targeting sites on nPTB24, as mentioned in section 1.1.1. In addition, miR-
124, and miR-9 are also repressed by the REST complex, as well as activated by Ascl1.
Observing the time series of the microRNAs in figure 6, the curves have almost identical
dynamics. For these reasons, we combine them into a single node that is denoted miR.
This reduces the number of parameters in the network, facilitating the process of fitting
network topologies to data. Merging miR-124 and miR-9 to a single node constrains us to
optimize this node using only one time series. The dynamics are similar between the two
curves, making the choice arbitrary. Here, we choose the miR-124 data. Note that this
merge is made solely for facilitating the parameter optimization.
The reprogramming cocktail we model uses transduction of Ascl1 and REST inhibition,
the best performing cocktail in vitro mentioned in section 3.1. In this thesis, transducted
Ascl1 is denoted viral Ascl1 (virA), and REST inhibition is denoted RESTi. RESTi is
modeled as an unknown parameter in the model that appears in the denominator of equa-
tion (29). Note that short hairpin REST (shREST) in figure 7 symbolizes RESTi. This
parameter represents REST knockdown. Observing equation (29), REST would evidently
decrease by letting RESTi increase, resulting in low REST, as well as RESTc. Ascl1 is
modeled in a different way since both viral and endogenous levels are measured in the
experiment. The extreme difference in concentration levels between viral and endogenous
Ascl1 are challenging to fit with a single rate equation. The reason being that fitting to
viral Ascl1 immediately saturates this node, which then affects all other nodes in the net-
work, either repressing or activating them strongly. Ultimately, it is the endogenous curve
that is interesting to our model. Therefore, we separate viral and endogenous Ascl1. In
the cell viral Ascl1 will still take part in the majority of interactions because of the high
concentration. To account for this fact, we replace the endogenous Ascl1 term with a viral
Ascl1 term in interactions that would normally, without transduction of Ascl1, occur in
proportion to endogenous levels. The viral part is modeled as a constant parameter that
symbolizes a saturated value of Ascl1 in the cell. We chose the value of viral Ascl1 to be
1. The endogenous part can then be represented by rate equation (27).
In contrast to the experimental time series which symbolizes bulk concentrations, the
model portrays the behavior of a single cell. Therefore, we assume that the single cell gene
expression resembles that of the bulk concentration. Furthermore, RESTc is modeled as
composed of two components, REST and SCP1, while in nature the complex consist of
more components19.
In summary, the regulatory gene network presented here is based on key assumptions
derived from the methods we use and experimental data. These assumptions are listed
below.
• Viral and endogenous Ascl1 are separate and viral Ascl1 is constant throughout
experiment.
• Bulk time series are indicative of single cell time series.
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• The essential steps in transdifferentiation occur in the first 5 days.
• microRNA 124 and 9 have similar dynamics and can be merged to a single node.
• RESTc is composed of two components, REST and SCP1.
3.3 Fitting the network to time series
Determining a set of parameters for a given topology is achieved by fitting equations (26)-
(31) with the corresponding time series in figure 6. We use simulated annealing and genetic
algorithm for the parameter optimization. The genetic algorithm performed the best, re-
sults are shown in figure 8. Orange dots characterize median values from figure 6. Blue
curves characterize the best deterministic fit. The corresponding set of model parameters
producing these curves can be seen in appendix D.
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Figure 8: Best deterministic fit of winning topology. Here, orange dots depict data, con-
nected with orange lines. Blue curves represent model simulation results with the best
parameter values. The REST complex (RESTc) is included to show how it evolves as a
function of SCP1 and REST.
Figure 8 shows SCP1 and REST having similar dynamics to the experimental time se-
ries. These are key regulatory genes that are important to achieve an accurate description
of the underlying processes. Transduction of viral Ascl1 results initially in a sharp decrease
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of SCP1 and PTB through miR, seen between data points at t = 0 hours and t = 8 hours.
Repressing PTB relieves the repression on nPTB, resulting in an upregulation of SCP1. A
positive feedback between the complex and its components results in an upregulation of
SCP1, REST, RESTc, PTB, and a downregulation of nPTB and miR. Endogenous Ascl1
level was largely unchanged, the reasons is that RESTc is still repressing it and nPTB
is not activating it strongly enough. At a later stage, upregulation of miR through viral
Ascl1 manages to overcome RESTc, and the non-neuronal genes are again downregulated.
At this point miR has reached such a high concentration that RESTc is staying low. En-
dogenous Ascl1 is upregulated as nPTB keeps increasing, and RESTc keeps decreasing,
seen from the data point at t = 48 hours and onward.
The general trend of each node has been reproduced by the corresponding determin-
istic solution. Possible improvements involve a better downregulation of miR at t = 24
hours, as well as a smoother behavior of PTB, SCP1, and REST between t = 48 hours and
t = 72 hours. In the 48 − 72 hour time region, a dimple appears, even though intuitively
a smoother behavior would be more likely in this region. The experimental time series
seem to suggest that the transdifferentiation process has key regulatory switches during
the conversion.
The regulatory gene network represents a kind of artificial cell following the exper-
imental bulk concentration. Figure 9 shows deterministic time evolutions with different
levels of perturbation on the binding affinity of PTB on SCP1, see s5 in equation (29).
Depending on the value of the binding affinity, the artificial cell evolves into two distinct
states (blue or red). In the blue state neuronal genes nPTB, miR, and endogenous Ascl1
are enhanced, while in the red state they are repressed. Non-neuronal genes PTB, SCP1,
and REST showed anti-correlated behavior with the neuronal genes in each state. This
rapid transition suggests that controlling SCP1 is an important part for the transdiffer-
entiation procedure. One reason for this, is that SCP1, together with REST, builds the
complex repressing the neuronal genes. Thus, it is not unlikely that to achieve high yield
conversion, other complex compounds besides REST ought to be controlled. SCP1 also
has a relatively central role in our model with many genes affecting it, suggesting it has a
key role in the transdifferentiation.
Examination of the other binding affinities on SCP1 revealed that the RESTc binding
affinity also produce a rapid transition. Increasing the effect of nPTB on SCP1 through
its binding affinity yields no rapid transition. In this case nPTB induces the RESTc-PTB-
nPTB pathway, repressing itself through non-neuronal genes. The miR-124 binding affinity
was also unable to produce a rapid transition.
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Figure 9: Deterministic time evolutions of slightly perturbing the binding affinity of PTB
on SCP1, see parameter s5 in equation (29). All other parameters were kept constant.
Blue curves evolve to a neuronal like state and red curves evolve to a non-neuronal like
state. Note the rapid transition seen in the system. This suggests that the network has a
bistable region and that SCP1 is an important node to control during the conversion. The
y-axis illustrates the relative fold to fibroblast levels and the x-axis the simulation time.
The time scale has now changed as perturbing the binding affinity results in skewing the
effect of PTB on SCP1. The parameter range is s5 ∈ [3.3, 3.317], using a step size of 0.001.
3.4 Stochastic simulations
The stochastic nature of reactions result in varying time evolutions of a compound. Sim-
ulating an ensemble of cells using a deterministic approach yields no additional informa-
tion, as with no noise, each cell produces the same time evolution. On the other hand,
introducing noise, such that each cell in the ensemble behaves differently, yields a more ac-
curate picture of how the regulatory gene network would behave in nature. We conducted
stochastic simulations using the Gillespie algorithm, previously described in section 2.3.
The simulations use the parameters of the best deterministic fit. Perturbing the bind-
ing affinity, cells differentiated into two different states, a neuronal- and non-neuronal like
state. Specifically, we studied the interactions of SCP1, to gain further understanding of
the importance of controlling the REST complex during transdifferentiation.
Figure 10 shows 4 different stochastic simulations, each containing an ensemble of 100
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cells. All cells are initialized with the experimental bulk concentration at time t = 0 hours.
The time span of the simulations is between t = 0 hours and t = 120 hours, the same as the
deterministic simulation. In figures 10a-d, the dotted blue lines represent the deterministic
fits of figure 8. These dotted curves indicate how closely a cell follows the deterministic
dynamics. Figure 10b and c show cyan curves representing cells that follow the determin-
istic solution relatively closely, and red curves representing cells deviating comparatively
strongly from this state. Cyan cells have low neuronal repression, meaning nPTB, Ascl1,
and miR are upregulated, while, red cells has strong neuronal repression with REST, SCP1,
and PTB upregulated. This is similar to the two deterministic states mentioned previously.
We use endogenous Ascl1 to characterize a cell as having either a high or low neuronal
repression. A mean value of the concentration from the last hour is calculated for the
deterministic and stochastic endogenous Ascl1. The ratio between the stochastic and de-
terministic mean value is compared to a threshold value. If the ratio is larger than or equal
to this value, the stochastically evolving cell is counted as a neuronal cell. The threshold
value is 0.01, determined by hand.
The cells in the four stochastic simulations have different binding affinities of PTB on
SCP1. The values used are near the critical range found in the deterministic simulation.
Figure 10a shows the result of increasing the binding affinity to a relatively high value. In-
creasing the binding affinity symbolizes in this case increasing the effect of PTB on SCP1.
From an ensemble of 100 cells, only a single cell ends up in the neuronal-like state. Note
that each figure, 10a, b, c, and d, is accompanied by a histogram, detailing the percent of
cells in the respective state. The histograms use a shorthand notation of state 0 (red) for
characterizing high neuronal repression and state 1 (cyan) for characterizing low neuronal
repression. Decreasing the binding affinity, meaning we lower the strength of the effect on
SCP1 from PTB, results in figure 10b. Here, 75 cells end in state 0 while 25 cells end in
state 1. The non-neuronal state is still dominating, though lowering the binding affinity
clearly produced an increase in neuronal-like cells. In figure 10c, decreasing the binding
affinity even more leads to a switch with the neuronal state as the dominant attractor of
the system. The conversion rate is not ideal, 65 cells end in state 1 and 35 cells in state 0.
Figure 10d illustrates the time evolution of the ensemble of cells using the default binding
affinity, found through the deterministic procedure. Here, 100 cells end in the neuronal
state. Other sources of noise effecting the conversion, besides the background noise of
Gillespie, are not included in our simulations. Including these will likely result in a lower
conversion rate, closer to that observed experimentally.
In summary, transdifferentiation is in our model conducted through overexpressing
Ascl1 transcription factor and repressing the gene expression of REST, based on experi-
mental results by our collaborators25. Using established connections, as well as introducing
hypothetical interactions for SCP1, REST, PTB and nPTB, we found a regulatory gene
network able to fit experimental time series data, see figure 8 and equations (26)-(31).
Further investigating the network dynamics showed that perturbing the binding affinity
(s5 in equation (29)) on SCP1 from PTB yield a rapid transition, see figure 9. This sug-
gests that there exist at least two attractors for the regulatory gene network. Performing
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stochastic simulations showed that the regulatory gene network model exhibits two attrac-
tors, a neuronal- and non-neuronal. Systematically lowering the binding affinity from a
relatively high value to the value found through the parameter optimization, we observed
both attractors. At high respectively low binding affinity, the cells were more prone to
evolve into the corresponding non-neuronal respectively neuronal attractor. Between these
extremes, cells would evolve into both attractors.
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Figure 10: Stochastic simulations of 100 cells initialized with the experimental concentra-
tion at time t = 0. Here, the binding affinity parameter of PTB in rate equation (29), is
changed between each figure. Two states can be distinguished, a neuronal- (cyan) respec-
tively non-neuronal (red) state. Red curves represent cells in state 0, a state with high
repression of neuronal genes. Cyan curves represent cells with low repression of neuronal
genes, meaning they follow the deterministic solution to a degree. Histograms in each
figure show the percent of cells in the respective state. For comparison, the best determin-
istic fit is included, blue dotted lines. (a) Highly perturbed binding affinity of PTB in the
SCP1 rate equation. Here, the non-neuronal state is dominating strongly. (b) Lowering
the perturbation to some degree results in 75 non-neuronal cells and 25 neuronal cells. The
dominant state is still the non-neuronal state. (c) Further lowering the perturbation shifts
the system. Here, neuronal state 1 is dominating, with 65 cells in this state and 35 cells in
the non-neuronal state. (d) Using parameters from the best deterministic fit, all cells stay
in the neuronal state. Endogenous Ascl1 is used to identify which state a cell is in. The
curves are plotted from time t = 0 to t = 120.
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4 Discussion and conclusions
In this thesis, we have studied direct lineage reprogramming from human adult fibroblast
cells to neurons in silico. A computational model capturing the main parts of this transdif-
ferentiation could facilitate the experimental search of a high yield conversion scheme. The
advantage is that testing the dynamics of the transdifferentiation is relatively time efficient.
The model is constructed on experimental results of two regulatory loops23,24. Merging
the two loops and incorporating hypothetical interactions enabled us to find a regulatory
gene network able to reproduce experimental time series. Experimental research by our
colleges, Drouin-Ouellet et al. 25 , suggests RESTc as a key reprogramming barrier in the
transdifferentiation. Therefore, we focus on RESTc and its components when incorporating
hypothetical interactions with the rest of the nodes in the network. Transdifferentiation is
in our model performed by overexpressing Ascl1 and repressing REST, the best performing
cocktail experimentally25.
Using two global search methods, simulated annealing and genetic algorithm, we searched
for a winning network. The winning topology is shown in figure 7, with rate equations (26)-
(31). Here, the connections between RESTc and SCP1, RESTc and REST, RESTc and
PTB, nPTB and Ascl1, and nPTB and SCP1, are predictions of our model. The winning
set of parameters produced curves that fit well to experimental data. Some characteris-
tics still need to be addressed: first the downregulation of miR at time t = 24 hours is
not captured by the model. Here, the miR expression level is plateauing instead of being
downregulated. A likely explanation of the plateau effect on miR is the constant activation
by viral Ascl1. Second, the small dimples seen in the non-neuronal genes, PTB, SCP1, and
REST, are interesting. This is likely a compensation made by the algorithm to improve
the fitting, though it is possible a natural phenomenon exists behind it.
Using the rate equations and determined parameters, we performed deterministic and
stochastic simulations of the system. Perturbing the system, a rapid transition between
two attractors was identified in the deterministic case. Further investigation using the
stochastic approach confirmed the existence of two attractors in the model. The two at-
tractors symbolize a neuronal- and a non-neuronal cell state. The transition between the
two states was identified by perturbing SCP1, which is a component of RESTc. Specifi-
cally, it was the perturbation of the PTB binding affinity on SCP1 that caused the rapid
transition. From the perturbation studies, we predict that controlling not only REST but
also those components recruited by it is important for obtaining a high yield conversion
scheme.
In summary, the suggested model is capable of capturing the main features of the ex-
perimental time series. Perturbation studies revealed two attractors of the model. These
attractors are in agreement with the expected behavior that a cell would have in vitro
during neural transdifferentiation. Either a cell is in a non-neuronal state, or in a neu-
ronal state. The model could be expanded to include more nodes. However, this adds
complexity during the process of fitting model parameters. Modeling a RESTc consisting
of additional components may prove important if the model is to be extended to include
37
a more detailed network. Such an approach could explore the components significance in
neuronal reprogramming. For the system we model here, SCP1 and REST seem sufficient
to characterize RESTc. With these simplifications in mind, it is pleasing that the model
is able to capture the main parts of the transdifferentiation process.
To validate the model, the hypothetical interactions need to be verified. It is possible
that the direct connections between genes made here are the result of a longer chain of
interactions. An interesting point would be if these hypothetical interactions are indeed
part of the cell regulatory circuit. This will be one of the most crucial parts for the
regulatory gene network obtained in this study. Verifying the trend seen in the bulk time
series with single cell time series is also essential for the regulatory gene network presented
here.
Future work with this model involves extending it further, such that it includes the
process of generating dopaminergic neurons. Here, the experimental conversion rate is still
relatively low. This would further our understanding of the dynamics that occur in the cell,
hence facilitating the process of obtaining a high yield dopaminergic conversion scheme.
Such a breakthrough would possibly open up new pathways for medical treatments and
disease modeling of diseases such as Parkinson’s disease.
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Appendices
A Implementation details
In both search methods viral Ascl1, see section 3.2, is set as a constant parameter. We
choose the value of this parameter (virA in equation (31)) to be 1, representing a normalized
level. The best deterministic fit is shown in figure 8, other tested network topologies are
shown in appendix C. The simulation time, represented on the x-axis of figure 8, is from
t = 0 hours to t = 120 hours, with data points at tp ∈ {0, 8, 24, 48, 72, 120}. In the
simulated annealing approach, parameters are initialized randomly within set ranges, see
table 1. The rate equations were then solved using ode45 in MATLAB, a Runge-Kutta 4,5
(RK45) based differential equation solver. In the genetic algorithm approach, parameters
are initialized within the 64-bit floating point value. The rate equations were solved using
the standard RK4 method.
Simulated annealing
The objective function, also known as the cost function, is an important concept in sim-
ulated annealing. This is the function that translates each sampled state to an artificial
energy. The cost function is problem specific. The aim of the optimization is to produce
time evolutions that matches experimental time series. In order to perform such an opti-
mization, the cost function has to translate the difference between the generated theoretical
curves to the data as a single number, the artificial energy. In this work, we use a least
square cost function,
E =
∑
j
(∑
i
(xji − xji,data)2
)
. (32)
Here, the outer sum symbolizes each gene j, and the inner sum is over every matching pair
i between the generated gene expression xji and data point x
j
i,data.
Optimizing the fit to data is equivalent to minimizing equation (32). Since the level
of gene expression varies between genes (see figure 6), using a direct least square calcu-
lation will result in certain genes contributing more to the overall cost. To avoid this we
normalize the data in the simulated annealing approach, dividing every data point with
the maximum concentration value measured for that specific gene. The maximum value
divided by is chosen from the total time period that we fit to. After transforming the data,
each gene has a maximum concentration value of 1. In this way, if the order of magnitude
differs a lot between genes, the resulting cost will not be affected substantially. To further
facilitate the fitting process we use interpolated data points. These help the algorithm
trace data better as deviating solutions are penalized further. In this work we use a total
of 5 linearly interpolated points, one between every pair of adjacent data points.
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There exists a diverse number of cooling schemes, ranging from monotonically decreas-
ing functions to adaptive non-monotonically decreasing functions. The objective of the
cooling schedule is to reduce the temperature quickly while still slow enough such that the
algorithm is not trapped in a metastable state. The cooling schedule required is dependent
on the specific problem. In this work we use an exponential cooling schedule, which is a
common monotonically decreasing cooling schedule,
Tn = T0α
n. (33)
T0 is the starting temperature and α a parameter. In our simulations T0 = 1, and α = 0.9.
n denotes the number of temperature decrements. The temperature is updated until a
minimum temperature is reached. The state when T ≤ Tmin was kept as the final value.
The neighborhood or candidate function, the function that samples a new state from
the present state, can have a major impact on both the run time and the quality of result.
The regulatory gene network consists of 45 parameters in total. These parameters have
different degrees of sensitivity associated with them. A neighborhood function should
on average produce new states that correspond to small steps in the energy landscape.
Otherwise it may be difficult to fine tune the solution toward the global minimum. Thus,
we choose a random subset of parameters for updating, drawn with replacement. These
parameters are then perturbed around the present value. The function for perturbing a
parameter y can be summarized as the following,
ynew =
{
y · [1 + a (r − 1
2
)]
, R < 0.5,
y · [1 + b (r − 1
2
)]
, R ≥ 0.5. (34)
ynew denotes the updated value of parameter y. r and R are uniformly distributed random
numbers. The parameters a and b are positive constants that specify the allowed range
for the updated parameter. For our simulations a = 0.2 and b = 0.4. a is smaller than b
because this allows the algorithm to take both small and large steps. On average, small
perturbations are more likely to occur.
The updating strategy described above is used for all parameters except the Hill coef-
ficients, which are treated as integers,
Hnew =
{
H + sgn
(
1
2
− r) , R < 0.75,
H + 2 · sgn (1
2
− r) , R ≥ 0.75. (35)
Here, Hnew denotes the updated Hill coefficient, and H the current value. sgn represent
the sign function, with the properties sgn(x) = +1 for x > 0, sgn(x) = −1 for x < 0,
and 0 otherwise. r and R are uniformly distributed random numbers. Note, again, that
the second option corresponds to larger steps in the parameter space. The equations (34)
and (35) characterize the core of the neighborhood function. For every type of parameter
we also chose an allowed range. Updated parameters that exceed this range are set to the
corresponding minimum or maximum value. The set of ranges are shown in table 1.
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Table 1: The set of parameter ranges used in the simulated annealing approach.
si [0, 30]
bi [0, 1]
Hi [0, 10]
αi [0, 17]
γi [0, 4]
RESTi [0, 20]
Kd [0, 2]
Genetic algorithm
An individual in our model is constructed as an ordered list of gene values. The total
number of genes is determined by the topology of the regulatory gene network. The winning
regulatory gene network consists of 45 genes. A gene in our network is represented using a
floating point value representation. The value of a gene is directly read from the genome,
except for the Hill parameters, Hi, and the dimerization constant, Kd. These values are
chosen as constrained in the ranges [0, 10] respectively [0, 1]. A gene x, being a Hill- or
dimerization parameter, is transformed when read using,
x→ kx
1 + x
.
Here, k = 10 for a Hill parameter and k = 1 for the dimerization constant.
The genetic algorithm uses a tournament selection that is modified somewhat in compar-
ison to the description of the method given in section 2.2. Here, creating a new generation
is performed by breeding and removing a set of individuals and replicating the remaining
ones. Breeding a new individual is achieved by choosing two individuals and recombining
them. Thus, there exists a possibility for every individual to reproduce. Removing an
individual occurs by choosing a subset of 5 individuals from the current population and
removing the worst of them. This procedure is repeated four times for every generation.
The population size is 100 individuals.
Using the fourth order Runge-Kutta method, the time evolution is determined. Cal-
culating the fitness of an individual is done by summing two terms. The first term of the
fitness function stands for the least square error, previously described for the simulated
annealing approach (see equation (32)). Here, normalization is performed by taking the
difference, xji − xji,data, and divide by the corresponding maximum concentration in the
set of experimental values, {xdata}ji , for gene j. The resulting value is then squared as
usual and added to the overall fitness. The second term is a smoothing regularization
term that helps reduce oscillations in the fitted curves by penalizing rapid fluctuations.
This is achieved by numerically approximating the integral of the absolute value of the
first derivative for each rate equation. Each value calculated is normalized with respect
to the corresponding maximum value measured experimentally, similar to the least square
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method. The size of the penalization is scaled by a regularization parameter such that
the smoothing is not too extreme in comparison to the mean squared error of the time
evolutions. This regularization parameter is 1/20, determined by hand.
The crossover operation, performed when creating a new individual, is accomplished
by randomly combining the genes from each parent. Thus, for each of the 45 genes, the
children are given one at random from each parent. This is done in a sequential order such
that the position of each gene is conserved.
The mutation operation mutates each gene independently. Here, each gene is multi-
plied with three independently calculated factors that are either 1 or the exponential of
a normally distributed random number. The distributions are centered around 0 with
standard deviations log(1.01), log(1.05), and log(1.5). These factors represent respectively
very small, small, and large mutations. The probability of each mutation is p, p/3, and
p/10, with p = 2/45.
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B Complete time series
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Figure 11: Complete time series data of figure 6 on page 26. Data points are plotted at
times (0, 0.3, 1, 2, 3, 5, 7, 14, 21) measured in days. Note the time series of miR-9. Here,
the last data point illustrates the minimum value instead of the median value. The reason
for this is that the two other data points have extremely high values at roughly 4 · 104
and 2.7 · 104. Since data points are independent of each other, these extreme values may
represent time series that are overall much higher in concentration than other time series
corresponding to the other data points. For these reasons we neglect plotting the median
value at the last time point. Under these assumptions, the dynamics show that after day
5 the cells reach a steady state.
43
C Network topologies
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Figure 12: A set of tested network topologies together with the accompanied fits. Purple
arrows indicate which interaction is being tested. Note that the microRNAs 124 and 9 are
separated. The hypothetical interaction between RESTc and PTB, as well as nPTB and
Ascl1, are present in all simulations. From figure (e) and forward, the activation of SCP1
and REST were adopted as they improved the fitting. The fits shown here were generated
using the Simulated Annealing algorithm. The fits are plotted in the order of PTB, Ascl1,
SCP1, REST, nPTB, miR-124, miR-9, and RESTc. RESTc is not fitted to experimental
data. In the fits CTDSP1 is equivalent to SCP1.
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D Parameter set
Table 2: Parameter table of the best parameter values for equation (26)-(31). These values
were obtained by minimizing the fitness function of the genetic algorithm. Note that virA
is a constant parameter of the model. The resulting time evolutions are shown in figure 8.
(a) Table 1
α1 0.5508
α2 5.6378
α3 2.0636
α4 1.6195
α5 1.6073
α6 0.3443
b1 0.0011
b2 4.4487·10−6
b3 0.0084
b4 1.3359
b5 0.0327
s1 4.5607
s2 0.4070
s3 0.2462
s4 8.5180
s5 0.0430
s6 0.0616
s7 1.1035
s8 6.3755
s9 2.8500
s10 0.3135
s11 1.9862
s12 5.9762
s13 3.1450
(b) Table 2
H1 1.5806
H2 1.1495·10−5
H3 10.0000
H4 4.3678
H5 3.2549
H6 2.7423
H7 3.8116
H8 1.8091
H9 2.3217
H10 3.3484
H11 5.5800
H12 1.0000
H13 3.0609
γ1 0.3235
γ2 1.2013·10−6
γ3 0.3502
γ4 0.9509
γ5 0.0082
γ6 0.0291
RESTi 3.3827
Kd 0.7595
virA 1
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